Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 22 February 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Obesity increases the risk for GERD

Obesity is associated with an increase in the risk for GERD symptoms, erosive esophagitis, and esophageal adenocarcinoma, a risk that increases with increasing weight, reports the latest issue of Annals of Internal Medicine.

News image

fiogf49gjkf04

The association of body mass index and gastroesophageal reflux disease (GERD) is unclear.

There is also uncertainty about the association between body mass index and GERD complications such as esophagitis, Barrett esophagus, and esophageal adenocarcinoma.

Dr Hashem El-Serag and colleagues from Texas conducted a systematic review and meta-analysis to evaluate this association.

The magnitude of an association between obesity and GERD, erosive esophagitis, Barrett esophagus, and adenocarcinoma of the esophagus and of the gastric cardia was estimated.

The research team searched MEDLINE between 1966 and 2004 for published full studies.

The researchers included studies that provided risk estimates and met criteria on defining exposure and reporting outcomes and sample size.

Data was extracted by 2 researchers independently performing a standardized search.

Odds ratio for GERD symptoms was 1.9 for body mass index greater than 30 kg/m2
Annals of Internal Medicine

The team obtained unadjusted and adjusted odds ratios for individual outcomes or calculated for each study and were pooled by using a random-effects model.

The researchers found that 9 studies examined the association of body mass index with GERD symptoms.

The team noted that 6 of these studies found statistically significant associations.

The researchers also noted that 6 of 7 studies found significant associations of body mass index with erosive esophagitis, and esophageal adenocarcinoma.

A significant association with gastric cardia adenocarcinoma was found in 4 out of 6 studies.

In data from 8 studies, the team found a trend toward a dose-response relationship.

There was an increase in the pooled adjusted odds ratio for GERD symptoms of 1.4 for a body mass index of 25 kg/m2 to 30 kg/m2.

The team observed that the pooled adjusted odds ratio for GERD symptoms was 1.9 for body mass index greater than 30 kg/m2.

Similarly, the pooled adjusted odds ratio for esophageal adenocarcinoma for a body mass index of 25 kg/m2 to 30 kg/m2 was 1.5.

The researchers found that with a body mass index greater than 30 kg/m2, the pooled adjusted odds ratio for esophageal adenocarcinoma was 2.8.

The team noted heterogeneity in the findings, although it was mostly in the magnitude of statistically significant positive associations.

In addition, the researchers reported that no studies in this review examined the association between Barrett esophagus and obesity.

Dr El-Serag's team concludes, “Obesity is associated with a statistically significant increase in the risk for GERD symptoms, erosive esophagitis, and esophageal adenocarcinoma.”

“The risk for these disorders seems to progressively increase with increasing weight.”

Ann Int Med 2005: 143(3): 199-211
03 August 2005

Go to top of page Email this page Email this page to a colleague

 22 February 2018 
Outcomes with Crohn’s after infliximab withdrawal
 22 February 2018 
Elderly onset of IBD

 22 February 2018 
Autophagy enhancers
 21 February 2018 
Management of hemorrhoids in the USA
 21 February 2018 
Adalimumab and infliximab in biologic-naïve Crohn's
 21 February 2018 
Cystic fibrosis and colorectal cancer
 20 February 2018 
Complications and surveillance colonoscopies
 20 February 2018 
Treatment algorithm for polyp cancers
 20 February 2018 
Predictors of postoperative infection in Crohn's
 19 February 2018 
Screening colonoscopy in the right and left colon
 19 February 2018 
NAFLD prevalence in the USA
 19 February 2018 
Fructans in children with IBS

 16 February 2018 
Inflammatory bowel diseases are global diseases
 16 February 2018 
Undetected celiac in the elderly
 16 February 2018 
Fructans induce non-celiac gluten sensitivity
 15 February 2018 
NSAIDS and GI damage
 15 February 2018 
Oral direct-acting antiviral treatment for Hep C virus genotype 1
 15 February 2018 
Primary vs secondary surgery for the presence of lymph node metastasis
 14 February 2018 
Predicting adenoma detection rate
 14 February 2018 
Normal bowel frequency characterization in the USA 
 13 February 2018 
Personalising treatment options for IBS
 13 February 2018 
Prebiotics improve endothelial dysfunction
 13 February 2018 
Diagnostic criteria for a Rome IV functional gastrointestinal disorders
 12 February 2018 
Visceral hypersensitivity and functional GI disorders
 12 February 2018 
Depression and aggressive IBD
 12 February 2018 
Variability in interpretation of endoscopic findings impacts patient management
 09 February 2018 
Treatment of choice for anastomotic stricture in IBD
 09 February 2018 
PRO measurement information system 
 09 February 2018 
Overall disease severity indices for IBD
 08 February 2018 
Prediction of endoscopically active disease

 08 February 2018 
Steroid-refractory acute severe ulcerative colitis
 08 February 2018 
Decision aid used by IBD patients
 07 February 2018 
Ursodeoxycholic acid combined with bezafibrate for itching
 07 February 2018 
Change in microbiome in gastritis vs gastric carcinoma
 07 February 2018 
Colorectal cancer and primary sclerosing cholangitis-IBD
 06 February 2018 
Risk of death after liver transplantation
 06 February 2018 
Crohn’s disease vs refractory pouchitis
 06 February 2018 
Support for functional dyspepsia symptom diary
 05 February 2018 
Helicobacter spp influence on GI tract 
 05 February 2018 
No link found between severe reflux and all-cause mortality 
 05 February 2018 
Psychological distress in PPI non-responders
 02 February 2018 
Assessing psychosexual impact of IBD
 02 February 2018 
Decrease in overall mortality with cholera vaccination
 02 February 2018 
Diagnostic performance of fecal immunochemical tests
 01 February 2018 
Screening frequency with family histories of colorectal cancer
 01 February 2018 
IBD and sport participation
 01 February 2018 
Life with a stoma 
 31 January 2018 
Aprepitant and gastroparesis 
 31 January 2018 
Anesthesia risk in colonoscopy
 31 January 2018 
GED-0301 for Crohn's Disease
 30 January 2018 
Intestinal dysbiosis and allergic diseases in infants
 30 January 2018 
Fructans and IBS symptoms in children
 29 January 2018 
Dosing calculator for therapy optimization in IBD
 29 January 2018 
Glecaprevir–pibrentasvir for in HCV
 29 January 2018 
Food allergen injections in eosinophilic esophagitis
 29 January 2018 
Reliability of the IBD index
 26 January 2018 
Tofacitinib vs biological therapies for ulcerative colitis
 26 January 2018 
Optimizing selection of biologics in IBD
 26 January 2018 
Nutritional risk and laparoscopic-assisted gastrectomy outcomes
 25 January 2018 
Patient-reported outcome measure for functional dyspepsia

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us